Article info
PDFClinical science
Original article
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
- Correspondence to Dr SriniVas Sadda, Doheny Eye Institute, 1450 San Pablo Street, DEI 3623, Los Angeles, CA 90033, USA; sadda{at}usc.edu
Citation
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Publication history
- Accepted June 27, 2011
- First published July 26, 2011.
Online issue publication
December 12, 2011
Article Versions
- Previous version (26 July 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.